Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 143

Showing 26-50 of 143 citing articles:

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar
Patrick Tang, Mohammad R. Hasan, Hiam Chemaitelly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 71
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
Fatiha M. Benslimane, Hebah A. Al-Khatib, Ola Al-Jamal, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 65
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
PLoS Medicine (2021) Vol. 18, Iss. 12, pp. e1003879-e1003879
Open Access | Times Cited: 64
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
Shaheen Seedat, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 63
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e944-e955
Open Access | Times Cited: 59
COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
Adeel A. Butt, Soha R. Dargham, Patrick Tang, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 57
Covid-19 Vaccine Protection among Children and Adolescents in Qatar
Hiam Chemaitelly, Sawsan AlMukdad, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 20, pp. 1865-1876
Open Access | Times Cited: 55
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 54
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
EBioMedicine (2023) Vol. 95, pp. 104734-104734
Open Access | Times Cited: 32
Wound healing capability of the double-layer Polycaprolactone/Polyvinyl alcohol-Chitosan lactate electrospun nanofiber incorporating Echinacea purpurea extract
Shohreh Fahimirad, Parastu Satei, Ali Ganji, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104734-104734
Closed Access | Times Cited: 26
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
American Journal of Epidemiology (2023) Vol. 193, Iss. 6, pp. 883-897
Open Access | Times Cited: 25
All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic
Asma Ali Al-Nuaimi, Hiam Chemaitelly, Sandy Semaan, et al.
BMJ Global Health (2023) Vol. 8, Iss. 5, pp. e012291-e012291
Open Access | Times Cited: 23
Investigation of a novel bilayered PCL/PVA electrospun nanofiber incorporated Chitosan-LL37 and Chitosan-VEGF nanoparticles as an advanced antibacterial cell growth-promoting wound dressing
Shohreh Fahimirad, Mohsen Khaki, Ehsanollah Ghaznavi‐Rad, et al.
International Journal of Pharmaceutics (2024) Vol. 661, pp. 124341-124341
Closed Access | Times Cited: 8
A review of mathematical model-based scenario analysis and interventions for COVID-19
Regina Padmanabhan, Hadeel S. Abed, Nader Meskin, et al.
Computer Methods and Programs in Biomedicine (2021) Vol. 209, pp. 106301-106301
Open Access | Times Cited: 51
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1188-e1191
Open Access | Times Cited: 48
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
Hiam Chemaitelly, Patrick Tang, Mohammad R. Hasan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 46
Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar
Roberto Bertollini, Hiam Chemaitelly, Hadi M. Yassine, et al.
JAMA (2021) Vol. 326, Iss. 2, pp. 185-185
Open Access | Times Cited: 43
Psychological impact of the COVID-19 pandemic within institutional quarantine and isolation centres and its sociodemographic correlates in Qatar: a cross-sectional study
Shuja Reagu, Ovais Wadoo, Javed Latoo, et al.
BMJ Open (2021) Vol. 11, Iss. 1, pp. e045794-e045794
Open Access | Times Cited: 40
Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
Houssein H. Ayoub, Ghina R. Mumtaz, Shaheen Seedat, et al.
Global Epidemiology (2021) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 40
Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 36
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 32
Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant
Heba N. Altarawneh, Hiam Chemaitelly, Patrick Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
Elias Tayar, Sami Abdeen, Muna Abed Alah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 2, pp. 250-256
Open Access | Times Cited: 29
Protection of SARS-CoV-2 natural infection against reinfection with the Omicron BA.4 or BA.5 subvariants
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 27
Prevalence of hepatitis B and C viruses among migrant workers in Qatar
Gheyath K. Nasrallah, Hiam Chemaitelly, Ahmed Ismail, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Scroll to top